[1]张莹莹 张丽丽 杨庆辉.白细胞介素-6与肿瘤坏死因子-α在心房颤动中的作用研究进展[J].心血管病学进展,2020,(2):132-135.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.008]
　Zhang YingyingZhang LiliYang Qinghui.The Role of Interleukin-6 and Tumor Necrosis Factor- in Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(2):132-135.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.008]
点击复制

白细胞介素-6与肿瘤坏死因子-α在心房颤动中的作用研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年2期
页码:
132-135
栏目:
综述
出版日期:
2020-02-25

文章信息/Info

Title:
The Role of Interleukin-6 and Tumor Necrosis Factor- in Atrial Fibrillation
作者:
张莹莹 张丽丽 杨庆辉
(哈尔滨医科大学附属第四医院心血管内科,黑龙江 哈尔滨 150001)
Author(s):
Zhang YingyingZhang LiliYang Qinghui
(Department of Cardiology,The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China)
关键词:
白细胞介素-6; 肿瘤坏死因子-α; 心房颤动
Keywords:
Interleukin-6; Tumor necrosis factor-; Atrial fibrillation
DOI:
10.16806/j.cnki.issn.1004-3934.2020.02.008
摘要:
心房颤动的发病率逐年升高，明显影响患者的生存质量，当前主流的治疗方法仍存在较多缺陷，新的治疗靶点亟待突破。近年研究发现，炎症反应在心房颤动病理生理过程中广泛存在，炎症因子中白细胞介素-6及肿瘤坏死因子-α可使心房颤动进一步发展，具有重要地位。现就近年关于白细胞介素-6及肿瘤坏死因子-α在心房颤动中的作用研究进展做一综述。
Abstract:
The incidence of atrial fibrillation is increasing year by year, which obviously affects the quality of life of patients. Currently, there are still many defects in the mainstream treatment. Therefore, new therapeutic targets are urgently needed to be broken through. In recent years, it has been found that inflammatory responses are widespread in the pathophysiological process of atrial fibrillation, and interleukin-6 and tumor necrosis factor-α play an important role in the development of atrial fibrillation. Recent advances in interleukin-6 and tumor necrosis factor-α in atrial fibrillation will reviewed in this article

参考文献/References:

[1]Ball J,Carrington MJ, McMurray JJ,et al.Atrial fibrillation:profile and burden of an evolving epidemic in the 21st century[J].Int J Cardiol,2013167(5):1807-1824.
[2]Lau DH,Nattel S,Kalman JM,et al.Modifiable risk factors and atrial fibrillation[J].Circulation,2017,136(6):583-596.
[3]Tanaka T,Narazaki M,Masuda K,et al.Regulation of IL-6 in immunity and diseases[J].Adv Exp Med Biol,2016,941:79-88.
[4]Wang J,Chen D,Cheng XM,et al.Influence of phenotype conversion of epicardial adipocytes on the coronary atherosclerosis and its potential molecular mechanism[J].Am J Transl Res,2015,7(10): 1712-1723.
[5]Wang D,Zhou Y,Lei W,et al.Signal transducer and activator of transcription 3 (STAT3) regulates adipocyte differentiation via peroxisome-proliferator-activated receptor gamma (PPARgamma)[J].Biol Cell,2009,102(1):1-12.
[6]O’Shea JJ,Schwartz DM,Villarino AV,et al.The JAK-STAT pathway:impact on human disease and therapeutic intervention[J].Annu Rev Med,2015,66(1):311-328.
[7]Georgakopoulos C,Vlachopoulos C,Lazaros G,et al.Biomarkers of atrial fibrillation in metabolic syndrome[J].Curr Med Chem,2019,26(5):898-908.
[8]Allison MB,Myers MG Jr.20 years of leptin:connecting leptin signaling to biological function[J].J Endocrinol,2014,223(1):T25-35.
[9]Fukui A,Takahashi N,Nakada C,et al.Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation[J].Circ Arrhythm Electrophysiol,2013,6(2):402-409.
[10]Ermakov S,Azarbal F,Stefanick ML,et al.The associations of leptin,adiponectin and resistin with incident atrial fibrillation in women[J].Heart,2016,102(17):1354-1362.
[11]Hatem SN. Atrial fibrillation and obesity:not just a coincidence[J].J Am Coll Cardiol,2015,66(1):12-13.
[12]冯馨锐,崔雨舒,何志涛,等.肿瘤坏死因子-α的生物学功能研究进展[J].吉林医药学院学报,201940(1):66-68.
[13]Kitagawa T,Yamamoto H,Hattori T,et al.Tumor necrosis factor-alpha gene expression in epicardial adipose tissue is related to coronary atherosclerosis assessed by computed tomography[J].J Atheroscler Thromb,2018,25(3):269-280.
[14]Aschar-Sobbi R,Izaddoustdar F,Korogyi AS,et al.Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFalpha[J].Nat Commun,2015,6:6018.
[15]Dai H,Wang X,Yin S,et al.Atrial fibrillation promotion in a rat model of rheumatoid arthritis[J].J Am Heart Assoc,2017,6(12).?pii: e007320.?
[16]马瑞彦,肖颖彬.炎症与心房颤动—分子机制和治疗进展[J].心血管病学进展,2017,38(5):516-519.
[17]Karam BS,Chavez-Moreno A,Koh W,et al.Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes[J]. Cardiovasc Diabetol,2017,16(1):120.
[18]January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol,2014,64(21):e1-76.
[19]Rao F,Xue YM,Wei W,et al.Role of tumour necrosis factor-a in the regulation of T-type calcium channel current in HL-1 cells[J].Clin Exp Pharmacol Physiol,2016,43(7):706-711.
[20]Zhao Q,Zhang S,Zhao H,et al.Median nerve stimulation prevents atrial electrical remodelling and inflammation in a canine model with rapid atrial pacing[J].Europace,2018,20(4):712-718.
[21]Dzeshka MS,Lip GY,Snezhitskiy V,et al.Cardiac fibrosis in patients with atrial fibrillation:mechanisms and clinical implications[J].J Am Coll Cardiol,2015,66(8):943-959.
[22]Hu YF,Chen YJ,Lin YJ,et al.Inflammation and the pathogenesis of atrial fibrillation[J].Nat Rev Cardiol,2015,12(4):230-243.
[23]Procter NE,Stewart S,Horowitz JD.New-onset atrial fibrillation and thromboembolic risk:Cardiovascular syzygy?[J].Heart Rhythm,2016,13(6):1355-1361.
[24]Engelmann MD,Svendsen JH.Inflammation in the genesis and perpetuation of atrial fibrillation[J].Eur Heart J,2005,26(20):2083-2092.
[25]Bauer KA,ten Cate H,Barzegar S,et al.Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans[J].Blood,1989,74(1):165-172.
[26]Tocci G,Goletti D,Marino V,et al.Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease:a focus on rheumatoid arthritis[J].Expert Opin Drug Saf,2016,15(sup1): 55-61.
[27]de Fonseka AM,Tuskey A,Conaway MR,et al.Antitumor necrosis factor-alpha therapy is associated with reduced risk of thromboembolic events in hospitalized patients with inflammatory bowel disease[J].J Clin Gastroenterol,2016,50(7):578-583.
[28]Shields PG,Berman M,Brasky TM,et al.A review of pulmonary toxicity of electronic cigarettes in the context of smoking:a focus on inflammation[J]. Cancer Epidemiol Biomarkers Prev,2017,26(8):1175-1191.
[29]McEvoy JW,Nasir K,DeFilippis AP,et al.Relationship of cigarette smoking with inflammation and subclinical vascular disease the multi-ethnic study of atherosclerosis[J].Arterioscler Thromb Vasc Biol,2015,35(4):1002-1010.
[30]Lévy P,Kohler M,McNicholas WT,et al.Obstructive sleep apnoea syndrome[J].Nat Rev Dis Primers,2015,1:15015.
[31]Liu G,Yan YP,Zheng XX,et al.Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation[J]. Am J Cardiol,2014,114(10):1523-1529.

相似文献/References:

[1]谷阳 史亚非 张刚 张东营 张清.急性ST段抬高型心肌梗死患者血浆中性粒细胞明胶酶相关脂质运载蛋白水平与梗死后心室重构的相关性研究[J].心血管病学进展,2019,(5):836.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.042]
　GU Yang,SHI Yafei,ZHANG Gang,et al.Neutrophil Gelatinase-associated Lipocalin is Associated with Cardiac Remodeling in Patients with ST-segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(2):836.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.042]
[2]胡星 蒋炘纹 蒋礼 雷迁(.尿液中性粒细胞明胶酶相关脂质运载蛋白和白细胞介素-6水平对心脏外科术后患者严重液体超负荷的风险价值[J].心血管病学进展,2024,(3):283.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.020]
　HU Xing,JIANG Xinwen,JIANG Li,et al.Risk Value of Urinary Neutrophil Gelatinase-Associated Lipocalin and Interleukin-6 Levels on Severe Fluid Overload in Patients After Cardiac Surgery[J].Advances in Cardiovascular Diseases,2024,(2):283.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.020]

更新日期/Last Update: 2020-04-14